Abstract:Background and purpose:Choriocarcinoma is a highly malignant tumor,which metastasis could occur at early stage,the molecular mechanism is still under investigation.DLX4 is a member of homeodomain transcriptional factors,and its abnormal expression has a close correlation with mammary cancer,colon caner and so on.Based on our previous study that DLX4 was highly expressed in choriocarcinoma JEG-3 cell lines,we used RNAi to knock down the expression of DLX4,and aimed to explore the effect of DLX4 on the adhesion,movement and invasion ability of choriocarcinoma cells.Methods:DLX4 siRNA and control siRNA plasmid were constructed and transfected into choriocarcinoma cell line JEG-3 cells with LipofectamineTM2000.JEG-3 cells that expressed high level of DLX4 siRNA and control siRNA plasmid were selected and maintained with G418.The effect of RNAi was detected by western blot,and then the adhesion,movement and invasion ability of JEG-3 cells were investigated by cell-ECM adhesion assay,Transwell chamber and Transwell-Matrigel model,respectively.Results:DLX4 RNAi inhibited DLX4 protein expression specifically and effectively.The adhesion rate of the cells in JEG-3 siDLX4 group was(30.6±4.2)%,which was significantly less than(57.2±4.0)% in JEG-3 without transfenction and(51.6±3.9)% in JEG-3 scDLX4 groups(P0.01 and P0.05,respectively).The movement and invasion ability were evidently inhibited in JEG-3 siDLX4 group compared with those in JEG-3 non-transfenction and JEG-3 scDLX4 groups [(31±3),(21±4)/HP vs.(68±5),(64±4)/HP and(70±4),(67±5)/HP,respectively,P0.01],while the adhesion,movement and invasion ability of the cells between JEG-3 non-transfenction and JEG-3 scDLX4 groups were not different(all of P0.05).Conclusions:The knock-down of DLX4 by RNAi could prevent the adhesion and invasion ability of choriocarcinoma cells,which provides a new thought for further research in invasion and metastasis of choriocarcinoma.

RNAi screens identify CHD4 as an essential gene in breast cancer growth

CHD4 Has Oncogenic Functions in Initiating and Maintaining Epigenetic Suppression of Multiple Tumor Suppressor Genes

CHD4 acts as a prognostic factor and drives radioresistance in HPV negative HNSCC

CHD4 Mediates Proliferation and Migration of Non-Small Cell Lung Cancer Via the RhoA/ROCK Pathway by Regulating PHF5A

Chd4 is Associated with Poor Prognosis of Non- Small Cell Lung Cancer Patients Through Promoting Tumor Cell Proliferation

The Inhibitory Effect of DLX4 RNAi on Adhesion and Invasion Ability of Choriocarcinoma Cells

CHD4 Promotes Breast Cancer Progression As a Coactivator of Hypoxia-Inducible Factors.

CHD1L Promotes Cell Cycle Progression and Cell Motility by Up-Regulating MDM2 in Breast Cancer.

Resistance to therapy in BRCA2 mutant cells due to loss of the nucleosome remodeling factor CHD4

The Chromatin Remodeler CHD4 Sustains Ewing Sarcoma Cell Survival by Controlling Global Chromatin Architecture

CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo

CHD1L Regulates Cell Survival in Breast Cancer and Its Inhibition by OTI-611 Impedes the DNA Damage Response and Induces PARthanatos

Comprehensive Analysis of the Expression, Prognosis, and Immune Infiltrates for Chromodomain-Helicase-DNA-Binding Proteins in Breast Tumor

Cell-based siRNA screens highlight triple-negative breast cancer cell epigenetic vulnerability

CHD4 Promotes Acquired Chemoresistance and Tumor Progression by Activating the MEK/ERK Axis

The therapeutic potential of targeting the CHD protein family in cancer

Chromodomain Helicase DNA Binding Protein 5 Plays a Tumor Suppressor Role in Human Breast Cancer

CHD4 Mediates SOX2 Transcription Through TRPS1 in Luminal Breast Cancer

CHD4 promotes acquired chemoresistance and tumor progression by activating the MEK/ERK axis.

The germline factor DDX4 contributes to the chemoresistance of small cell lung cancer cells

Interfering CXCR4 Expression Inhibits Proliferation,adhesion and Migration of Breast Cancer MDA-MB-231 Cells